Association of phospholipase A2 receptor 1 polymorphisms with idiopathic membranous nephropathy in Chinese patients in Taiwan

Journal of Biomedical Science

Volumn 17, Issue 1, 2010, Pages

  Liu, Yu Huei ^a,b   Chen, Cheng Hsu ^c   Chen, Shih Yin ^a,b   Lin, Ying Ju ^a,b   Liao, Wen Ling ^a,b   Tsai, Chang Hai ^a,d   Wan, Lei ^a,b,d  

^a CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b CHINA MEDICAL UNIVERSITY   (Taiwan)

^c TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^d ASIA UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORESCENT DYE; PHOSPHOLIPASE A2 RECEPTOR; PHOSPHOLIPASE A2 RECEPTOR 1; UNCLASSIFIED DRUG; IMMUNOSUPPRESSIVE AGENT; PLA2R1 PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; CHINESE; CONTROLLED STUDY; DEATH; DISEASE COURSE; DNA POLYMORPHISM; FEMALE; GENETIC ASSOCIATION; GENETIC RISK; GENOTYPE; HAPLOTYPE; HUMAN; IDIOPATHIC MEMBRANOUS NEPHROPATHY; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MEMBRANOUS GLOMERULONEPHRITIS; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REMISSION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM; TAIWAN; ALLELE; ASIAN; GENE FREQUENCY; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED; TREATMENT OUTCOME;

ADULT; AGED; ALLELES; ASIAN CONTINENTAL ANCESTRY GROUP; DISEASE PROGRESSION; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GLOMERULONEPHRITIS, MEMBRANOUS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, PHOSPHOLIPASE A2; TAIWAN; TREATMENT OUTCOME;

EID: 77957656958     PISSN: 10217770     EISSN: 14230127     Source Type: Journal    
DOI: 10.1186/1423-0127-17-81     Document Type: Article

References (26)

1. Podocyte biology in human disease. JR de Zoysa PS Topham, Nephrology (Carlton) 2005 10 362 10.1111/j.1440-1797.2005.00401.x 16109083
2. Structure and function of podocytes: an update. P Mundel W Kriz, Anat Embryol (Berl) 1995 192 385 8546330
3. Podocyte antigens and glomerular disease. P Ronco H Debiec, Nephron Exp Nephrol 2007 107 41 10.1159/000107708 17726340
4. Direct podocyte damage in the single nephron leads to albuminuria in vivo. W Laurens C Battaglia C Foglieni R De Vos B Malanchini B Van Damme Y Vanrenterghem G Remuzzi A Remuzzi, Kidney Int 1995 47 1078 10.1038/ki.1995.154 7783404
5. Autoimmune kidney diseases. M Segelmark T Hellmark, Autoimmun Rev 2009 9 366 A371 10.1016/j.autrev.2009.11.007 19906361
6. The urinary podocyte as a marker for the differential diagnosis of idiopathic focal glomerulosclerosis and minimal-change nephrotic syndrome. T Nakamura C Ushiyama S Suzuki M Hara N Shimada I Ebihara H Koide, Am J Nephrol 2000 20 175 10.1159/000013580 10878397
7. The role of podocyte injury in the pathogenesis of focal segmental glomerulosclerosis. MM Schwartz, Ren Fail 2000 22 663 10.1081/JDI-100101955 11104157
8. Glomerular podocyte vacuolation in idiopathic membranous glomerulonephritis. T Toth S Takebayashi, Nephron 1992 61 16 10.1159/000186828 1528336
9. Idiopathic membranous nephropathy: management strategies. M Quaglia P Stratta, Drugs 2009 69 1303 10.2165/00003495-200969100-00002 19583450
10. Diagnosis and natural course of membranous nephropathy. RJ Glassock, Semin Nephrol 2003 23 324 10.1016/S0270-9295(03)00049-4 12923720
11. Receptors for a growing family of secreted phospholipases A2. G Lambeau M Lazdunski, Trends Pharmacol Sci 1999 20 162 10.1016/S0165-6147(99)01300-0 10322502
12. The human 180-kDa receptor for secretory phospholipases A2. Molecular cloning, identification of a secreted soluble form, expression, and chromosomal localization. P Ancian G Lambeau MG Mattei M Lazdunski, J Biol Chem 1995 270 8963 10.1074/jbc.270.10.5534 7721806
13. M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy. LH Beck Jr RG Bonegio G Lambeau DM Beck DW Powell TD Cummins JB Klein DJ Salant, N Engl J Med 2009 361 11 21 10.1056/NEJMoa0810457 19571279
14. Bayesian haplotype inference for multiple linked single-nucleotide polymorphisms. T Niu ZS Qin X Xu JS Liu, Am J Hum Genet 2002 70 157 10.1086/338446 11741196
15. Impact of plasminogen activator inhibitor-1 gene polymorphisms on primary membranous nephropathy. CH Chen KH Shu MC Wen KJ Chen CH Cheng JD Lian MJ Wu TM Yu FJ Tsai, Nephrol Dial Transplant 2008 23 3166 10.1093/ndt/gfn258 18495745
16. TNFA2 and d2 alleles of the tumor necrosis factor alpha gene polymorphism are associated with onset/occurrence of idiopathic membranous nephropathy. D Thibaudin L Thibaudin P Berthoux C Mariat JP Filippis B Laurent E Alamartine F Berthoux, Kidney Int 2007 71 431 10.1038/sj.ki.5002054 17213876
17. Role of truncating mutations in MME gene in fetomaternal alloimmunisation and antenatal glomerulopathies. H Debiec J Nauta F Coulet M van der Burg V Guigonis T Schurmans E de Heer F Soubrier F Janssen P Ronco, Lancet 2004 364 1252 10.1016/S0140-6736(04)17142-0 15464186
18. An analysis of HLA class II gene polymorphism in British and Greek idiopathic membranous nephropathy patients. RW Vaughan MR Tighe K Boki S Alexoupolos J Papadakis JS Lanchbury KI Welsh DG Williams, Eur J Immunogenet 1995 22 179 10.1111/j.1744-313X.1995.tb00228.x 7605775
19. Factor B subtypes in Japanese patients with IgA nephropathy and with idiopathic membranous nephropathy. H Nishimukai I Nakanishi H Kitamura Y Tamaki, Exp Clin Immunogenet 1988 5 196 3272818
20. The C-type lectin superfamily in the immune system. WI Weis ME Taylor K Drickamer, Immunol Rev 1998 163 19 10.1111/j.1600-065X.1998.tb01185.x 9700499
21. The C-type carbohydrate recognition domain (CRD) superfamily. AJ Day, Biochem Soc Trans 1994 22 83 7515837
22. Controlled trial of methylprednisolone and chlorambucil in idiopathic membranous nephropathy. C Ponticelli P Zucchelli E Imbasciati, et al. N Engl J Med 1984 310 946 10.1056/NEJM198404123101503 6366560
23. Cyclosporine in patients with steroid-resistant nephrotic syndrome: an open-label, nonrandomized, retrospective study. GM Ghiggeri P Catarsi F Scolari G Caridi R Bertelli A Carrea S Sanna-Cherchi F Emma L Allegri G Cancarini GF Rizzoni F Perfumo, Clin Ther 2004 26 1411 10.1016/j.clinthera.2004.09.012 15531003
24. Prediction in idiopathic membranous nephropathy. BE Marx M Marx, Kidney Int 1999 56 666 10.1046/j.1523-1755.1999.00598.x 10432407
25. Prognostic factors in idiopathic membranous nephropathy. LJ Reichert RA Koene JF Wetzels, Am J Kidney Dis 1998 31 1 10.1053/ajkd.1998.v31.pm9428445 9428445
26. Association between genetic polymorphisms of the NPHS1 gene and membranous glomerulonephritis in the Taiwanese population. WY Lo SY Chen HJ Wang HC Shih CH Chen CH Tsai FJ Tsai, Clin Chim Acta 411 9-10 714 718 10.1016/j.cca.2010.02.004 20138859